Votrient liver data meta-analysis of phase II and III RCC and STS studies (200277)

Study identification

• EU PAS number:
  EUPAS6242
• Study ID:
  18181
• Official title and acronym:
  Votrient liver data meta-analysis of phase II and III RCC and STS studies (200277)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study status:
  Finalised

Research institutions and networks

Institutions

GlaxoSmithKline (GSK)

Study timelines

Date when funding contract was signed

Planned: 13/03/2013

Actual: 13/03/2013

Study start date

Planned: 07/04/2013

Actual: 07/04/2013

Date of final study report

Planned: 23/05/2013

Actual: 23/05/2013

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

GlaxoSmithKline

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable